4//SEC Filing
Shaaltiel Yoseph 4
Accession 0001209191-09-036036
CIK 0001006281other
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 5:00 PM ET
Size
6.6 KB
Accession
0001209191-09-036036
Insider Transaction Report
Form 4
Shaaltiel Yoseph
DirectorExecutive VP, R&D
Transactions
- Sale
Common Stock
2009-07-06$4.95/sh−20,000$99,000→ 1,363,754 total - Sale
Common Stock
2009-07-06$5.13/sh−80,000$410,400→ 1,383,754 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Documents
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeother
Related Parties
1- filerCIK 0001385118
Filing Metadata
- Form type
- 4
- Filed
- Jul 7, 8:00 PM ET
- Accepted
- Jul 8, 5:00 PM ET
- Size
- 6.6 KB